Medipharm Labs Corp T.LABS

Some of the trials information should be made public this

[subaru1i]

quarter.  Some people forget easiy...or conveniently....LABS stated they cannot dislcose much for "competitive reason" including the name of their global pharma partner but did say that Q4 disclosure of their Brazil pharma partner name is a possibility once ANVISA approves their submission.   

I guess some people just don't get it when it comes to secrecy for competitive reasons but just whine continually on the same topic.    

I wonder, is there a cannabinoid or combination there of to improve memory performance?  

With the right products being approved, North America or internationally, this stock could reach over $8 by the holiday season but those approvals are based on government health agencies and so too the timing of them.

FDA drug monograph, ANDA, NDA, 505(b), multiple approvals pending by ANVISA as well.

[subaru1]

For your memory they made it public 9 months ago, we are just asking an update of those 6 trials that they already made public. Actually they are acting as a private company and they are very to keep their investors well informed..

[subaru1i]

Pick up the phone, call them and present your questions and post their answers here..or...a bit late now, you should have called in the conference call and asked your questions in a public forum.   I tend to be thick headed as well at times but what part of the CEO telling shareholders, we cannot disclose more at this time for competitive reasons and that includes some of the trials they

[Redwine12345]

Be patient. I would not expect company releasing updates every 5 minutes. It takes time to conduct study and obtain results. If any significant change, they will disclose. They have no choice. No need reporting that trial participant went to washroom 3 times today. I would rather to hear that meds are improving or not his/her/it  health.